WO2007093608A8 - Arzneimittelkombinationen zur behandlung von atemwegserkrankungen - Google Patents
Arzneimittelkombinationen zur behandlung von atemwegserkrankungenInfo
- Publication number
- WO2007093608A8 WO2007093608A8 PCT/EP2007/051408 EP2007051408W WO2007093608A8 WO 2007093608 A8 WO2007093608 A8 WO 2007093608A8 EP 2007051408 W EP2007051408 W EP 2007051408W WO 2007093608 A8 WO2007093608 A8 WO 2007093608A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- drug combinations
- treatment
- respiratory tract
- tract diseases
- diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Abstract
Die vorliegende Erfindung betrifft neue Arzneimittelkombinationen, die neben einer oder mehrerer, bevorzugt einer Verbindung der allgemeinen Formel (1) worin A, B, R1, X, n und m die in den Ansprüchen und in der Beschreibung genannten Bedeutungen haben können, wenigstens einen weiteren Wirkstoff 2 enthalten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008554769A JP2009526817A (ja) | 2006-02-16 | 2007-02-14 | 呼吸器疾患の治療用医薬組成物 |
EP07726364A EP1986644A1 (de) | 2006-02-16 | 2007-02-14 | Arzneimittelkombinationen zur behandlung von atemwegserkrankungen |
CA002642239A CA2642239A1 (en) | 2006-02-16 | 2007-02-14 | Drug combinations for the treatment of respiratory tract diseases |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06110009.5 | 2006-02-16 | ||
EP06110009 | 2006-02-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007093608A1 WO2007093608A1 (de) | 2007-08-23 |
WO2007093608A8 true WO2007093608A8 (de) | 2007-11-22 |
Family
ID=35983924
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2007/051408 WO2007093608A1 (de) | 2006-02-16 | 2007-02-14 | Arzneimittelkombinationen zur behandlung von atemwegserkrankungen |
Country Status (7)
Country | Link |
---|---|
US (2) | US20070203125A1 (de) |
EP (1) | EP1986644A1 (de) |
JP (1) | JP2009526817A (de) |
AR (1) | AR059533A1 (de) |
CA (1) | CA2642239A1 (de) |
TW (1) | TW200803848A (de) |
WO (1) | WO2007093608A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20080142A1 (es) * | 2006-03-15 | 2008-04-14 | Boehringer Ingelheim Int | Beta-agonistas enantiomericamente puros y sus procedimientos de preparacion |
CN110003025A (zh) * | 2019-04-29 | 2019-07-12 | 天津华津制药有限公司 | 1-[2-羟基-3-氨基-5-(苄氧基)苯基]-乙酮的制备方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2609645A1 (de) * | 1976-03-09 | 1977-09-15 | Boehringer Sohn Ingelheim | Aminoalkylheterocyclen |
DE2833140A1 (de) * | 1978-07-28 | 1980-02-07 | Boehringer Sohn Ingelheim | Neue n-substituierte heterocyclen |
US6790856B2 (en) * | 2002-01-31 | 2004-09-14 | Boehringer Ingelheim Pharma Kg | Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments |
US7368435B2 (en) * | 2002-09-12 | 2008-05-06 | Summit Vetpharm, Llc | Topical endoparasiticide and ectoparasiticide formulations |
DE10253282A1 (de) * | 2002-11-15 | 2004-05-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung |
DE102004019540A1 (de) * | 2004-04-22 | 2005-11-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen |
EP1577306A1 (de) * | 2004-03-17 | 2005-09-21 | Boehringer Ingelheim Pharma GmbH & Co.KG | Neue Benzoxazinonderivate als langwirksame Betamimetika zur Behandlung von Atemwegserkrankungen |
US7244728B2 (en) * | 2004-03-17 | 2007-07-17 | Boehringer Ingelheim International Gmbh | Long acting betamimetics for the treatment of respiratory diseases |
US20050239778A1 (en) * | 2004-04-22 | 2005-10-27 | Boehringer Ingelheim International Gmbh | Novel medicament combinations for the treatment of respiratory diseases |
NZ550797A (en) * | 2004-04-22 | 2010-08-27 | Boehringer Ingelheim Int | Pharmaceutical combinations containing 6-hydroxy-8-{1-hydroxy-2-[2-(4-methoxy-phenyl)-1,1-dimethylethylamino]-ethyl}-4H-benzo[1,4]oxazin-3-one for treating respiratory diseases |
US7220742B2 (en) * | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
DE102004024454A1 (de) * | 2004-05-14 | 2005-12-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
DE102004045648A1 (de) * | 2004-09-21 | 2006-03-23 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Betamimetika zur Behandlung von Atemwegserkrankungen |
-
2007
- 2007-02-14 WO PCT/EP2007/051408 patent/WO2007093608A1/de active Application Filing
- 2007-02-14 CA CA002642239A patent/CA2642239A1/en not_active Abandoned
- 2007-02-14 JP JP2008554769A patent/JP2009526817A/ja active Pending
- 2007-02-14 EP EP07726364A patent/EP1986644A1/de not_active Withdrawn
- 2007-02-15 TW TW096105758A patent/TW200803848A/zh unknown
- 2007-02-16 AR ARP070100672A patent/AR059533A1/es not_active Withdrawn
- 2007-02-16 US US11/675,932 patent/US20070203125A1/en not_active Abandoned
-
2010
- 2010-08-02 US US12/848,364 patent/US20100297028A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2642239A1 (en) | 2007-08-23 |
US20100297028A1 (en) | 2010-11-25 |
US20070203125A1 (en) | 2007-08-30 |
TW200803848A (en) | 2008-01-16 |
WO2007093608A1 (de) | 2007-08-23 |
AR059533A1 (es) | 2008-04-09 |
EP1986644A1 (de) | 2008-11-05 |
JP2009526817A (ja) | 2009-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA85708C2 (ru) | Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей | |
WO2006099941A8 (de) | Aminocarbonyl substituierte 8-n-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
WO2007113558A8 (en) | Quinazolinone derivatives having b-raf inhibitory activity | |
WO2008000483A3 (en) | Phenol derivatives for the treatment of respiratory diseases | |
WO2009111700A3 (en) | Oxadiazoanthracene compounds for the treatment of diabetes | |
MX2007008924A (es) | Compuestos quimicos. | |
TW200736234A (en) | Chemical compounds | |
EP2305640A3 (de) | Substituierte Diphenyl-Ether, -Amine, -Sulfide und -Methane zur Behandlung von Beschwerden der Atemwege | |
TW200634003A (en) | Chemical compounds | |
TW200604196A (en) | New quinuclidine derivatives and pharmaceutical compositions comprising them | |
TW200616974A (en) | Chemical compounds | |
WO2007071963A3 (en) | Quinazoline derivatives, process for their preparation and their use as anti-cancer agents | |
WO2006096439A3 (en) | Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases | |
WO2005115470A3 (fr) | COMPOSITIONS PHARMACEUTIQUES CONTENANT DES DERIVES DE β-CARBOLINE, ET LEUR UTILISATION POUR LE TRAITEMENT DES CANCERS | |
TW200621259A (en) | Chemical compounds | |
MX2009004908A (es) | Compuestos quimicos. | |
WO2007009721A3 (en) | Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments | |
WO2008154083A3 (en) | Compounds, compositions and methods for the treatment of synucleinopathies | |
WO2007009720A3 (en) | Prodrugs of pyrazoline compounds, their preparation and use as medicaments | |
WO2007093880A3 (en) | Novel pyrone-indole derivatives and process for their preparation | |
EP2586427A3 (de) | Balsazidformulierungen und Herstellung und Verwendung davon | |
WO2007098964A3 (en) | Pyrrazole derivatives as sigma receptors antagonists | |
WO2009003719A3 (en) | Indane-amine derivatives, their preparation and use as medicaments | |
WO2009007300A3 (en) | Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufacture | |
WO2008146172A3 (en) | Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2007726364 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2642239 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008554769 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |